ArticleClinical ophthalmology (Auckland, N.Z.)2018

Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middle-income countries.

Hammouda Hamdy Ghoraba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.